Opening a door to safe abortion: international perspectives on medical abortifacient use.
International experience compels us to revisit how we define and assess the safety and efficacy of medical abortifacients such as misoprostol. In some countries where safe abortion is neither accessible nor legal, even unsupervised, off-protocol use of misoprostol can provide women with a means to safely terminate pregnancy. This is due primarily to misoprostol-induced uterine contractions that cause bleeding, which in turn provides access to existing reasonable quality health services that would otherwise be unavailable. Several studies have suggested that an increase in the underground use of misoprostol in Brazil has already reduced serious complications from unsafe abortion. Thus, the availability of medical abortifacients combined with strengthened postabortion care services can legitimately be considered a public health success in countries in which safe abortion services do not exist and law reform is unlikely.
Pollack
A E
AE
AVSC International, New York City, USA.
Pine
R N
RN
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000009:adverse effects; D000028:Abortion, Induced / Q000706:statistics & numerical data*; D000029:Abortion, Legal; D005260:Female; D014943:Global Health; D006297:Health Services Accessibility; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D011634:Public Health; D014592:Uterine Hemorrhage / Q000139:chemically induced / Q000628:therapy
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol